دورية أكاديمية
Trelegy Ellipta--a three-drug inhaler for COPD.
| العنوان: | Trelegy Ellipta--a three-drug inhaler for COPD. |
|---|---|
| المصدر: | The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2018 May 21; Vol. 60 (1547), pp. 86-88. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN: 1523-2859 (Electronic) Linking ISSN: 0025732X NLM ISO Abbreviation: Med Lett Drugs Ther Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New Rochelle, NY : The Medical Letter |
| مواضيع طبية MeSH: | Nebulizers and Vaporizers*, Adrenal Cortex Hormones/*administration & dosage , Adrenergic beta-2 Receptor Agonists/*administration & dosage , Androstadienes/*administration & dosage , Benzyl Alcohols/*administration & dosage , Bronchodilator Agents/*administration & dosage , Chlorobenzenes/*administration & dosage , Lung/*drug effects , Muscarinic Antagonists/*administration & dosage , Pulmonary Disease, Chronic Obstructive/*drug therapy , Quinuclidines/*administration & dosage, Administration, Inhalation ; Adrenal Cortex Hormones/adverse effects ; Adrenergic beta-2 Receptor Agonists/adverse effects ; Androstadienes/adverse effects ; Benzyl Alcohols/adverse effects ; Bronchodilator Agents/adverse effects ; Chlorobenzenes/adverse effects ; Drug Combinations ; Drug Interactions ; Humans ; Lung/physiopathology ; Muscarinic Antagonists/adverse effects ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Quinuclidines/adverse effects ; Treatment Outcome |
| فهرسة مساهمة: | Keywords: Advair; AirDuo; Anoro Ellipta; Bevespi Aerosphere; Breo Ellipta; COPD; Stiolto Respimat; Symbicort; Trelegy Ellipta; Utibron Neohaler; adverse effects; budesonide/formoterol; dosage; drug interactions; efficacy; fluticasone furoate; fluticasone propionate; formoterol; glycopyrrolate; indacaterol; long-acting beta2-agonists; olodaterol; pregnancy; safety; salmeterol; tiotropium; umeclidinium; umeclidinium/vilanterol; vilanterol |
| المشرفين على المادة: | 0 (Adrenal Cortex Hormones) 0 (Adrenergic beta-2 Receptor Agonists) 0 (Androstadienes) 0 (Benzyl Alcohols) 0 (Bronchodilator Agents) 0 (Chlorobenzenes) 0 (Drug Combinations) 0 (GSK573719) 0 (Muscarinic Antagonists) 0 (Quinuclidines) 028LZY775B (vilanterol) JS86977WNV (fluticasone furoate) |
| تواريخ الأحداث: | Date Created: 20180619 Date Completed: 20181105 Latest Revision: 20181105 |
| رمز التحديث: | 20240628 |
| PMID: | 29913467 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1523-2859 |
|---|